Physician profile

Amir Shariati

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) · Coconut Creek, FL

NPI 1386842136

$106,090.73

in general payments reported to CMS, 2019-2025

24 companies · $12K in 2025

The $12K reported for 2025 was more than what 95% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$15,557.50
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$11,514.00
Food and Beverage$3,563.77
Travel and Lodging$294.47
Education$5.49

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Coloplast Corp $50,645.02 2019-2025 Altis, Saffron
Boston Scientific Corporation $31,455.19 2019-2025 Solyx Sis System, Upsylon, Spyglass Discover
Intuitive Surgical, INC. $19,603.71 2021-2025 Da Vinci Surgical System
Medtronic USA, INC. $2,112.67 2019-2020
Medtronic, INC. $897.54 2021-2025 Interstim, Altaviva
Abbvie INC. $347.84 2022-2025 Botox
Axonics, INC. $195.27 2020-2023 Axonics
Escala Medical INC. $167.76 2024
Royal Biologics, INC. $102.20 2019
Pfizer INC. $69.25 2020-2023
Allergan, INC. $68.93 2019-2021
Urocure LLC $57.15 2020
Smith+Nephew, INC. $56.89 2021
Conmed Corporation $47.62 2022-2023 Airseal
Laborie Medical Technologies Corp. $40.20 2023-2024
Show all 23 companies
CompanyGeneral paymentsYearsTop products
Bluewind Medical $39.05 2024 Revi
Astellas Pharma US INC $35.90 2023 Veozah, Myrbetriq
Hologic Sales and Service, LLC $33.50 2025 Aptima
Mission Pharmacal Company $29.72 2019-2022
Abbott Laboratories $23.40 2024 Eterna
Ambu INC. $23.05 2025
Davol INC. $20.61 2021
Therapeuticsmd, INC. $18.26 2019

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$300,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Amir Shariati

$106,090.73

in general payments reported 2019-2025

Years
2019-2025
Top company
Coloplast Corp
Context
The $12K reported for 2025 was more than what 95% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).

https://glasscript.com/doctor/335619/amir-shariati

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.